Peloton Wealth Strategists’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4M Sell
11,360
-125
-1% -$44.6K 1.62% 21
2025
Q4
$3.76M Sell
11,485
-40
-0.3% -$12.7K 1.46% 23
2025
Q3
$3.25M Buy
11,525
+47
+0.4% +$13.6K 1.28% 25
2025
Q2
$3.21M Hold
11,478
1.29% 31
2025
Q1
$3.58M Buy
11,478
+200
+2% +$59.1K 1.49% 24
2024
Q4
$2.94M Sell
11,278
-2,025
-15% -$601K 1.19% 30
2024
Q3
$4.29M Sell
13,303
-5,840
-31% -$1.91M 1.7% 20
2024
Q2
$5.98M Sell
19,143
-280
-1% -$82.3K 2.46% 13
2024
Q1
$5.52M Sell
19,423
-550
-3% -$161K 2.24% 15
2023
Q4
$5.75M Sell
19,973
-780
-4% -$213K 2.49% 12
2023
Q3
$5.58M Sell
20,753
-448
-2% -$112K 2.57% 10
2023
Q2
$4.71M Sell
21,201
-718
-3% -$167K 2.08% 16
2023
Q1
$5.3M Sell
21,919
-148
-0.7% -$36.3K 2.42% 13
2022
Q4
$5.8M Sell
22,067
-170
-0.8% -$45.6K 2.79% 7
2022
Q3
$5.01M Buy
22,237
+29
+0.1% +$7.03K 2.61% 7
2022
Q2
$5.4M Sell
22,208
-547
-2% -$134K 2.63% 10
2022
Q1
$5.5M Buy
22,755
+952
+4% +$219K 2.3% 12
2021
Q4
$4.91M Buy
21,803
+490
+2% +$103K 1.97% 18
2021
Q3
$4.53M Buy
21,313
+2,040
+11% +$470K 1.86% 20
2021
Q2
$4.7M Buy
19,273
+3,465
+22% +$852K 1.94% 19
2021
Q1
$3.93M Buy
15,808
+6,070
+62% +$1.45M 1.85% 23
2020
Q4
$2.24M Buy
9,738
+3,595
+59% +$829K 1.11% 39
2020
Q3
$1.56M Buy
6,143
+5,163
+527% +$1.28M 0.87% 44
2020
Q2
$231K Buy
+980
New +$224K 0.15% 72

Other funds holding AMGN

Peloton Wealth Strategists's AMGN Position: Q1 2026 in Review

Peloton Wealth Strategists reduced its Amgen (AMGN) stake by 1.1% in Q1 2026, selling an estimated $44.6K and leaving 11,360 shares worth $4M. The position accounts for 1.62% of the portfolio, ranked #21.

Peloton Wealth Strategists first reported a position in AMGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $5.98M in Q2 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Peloton Wealth Strategists held 11,360 shares of Amgen worth $4M as of Q1 2026.
  • Peloton Wealth Strategists sold 125 Amgen shares in Q1 2026, an estimated $44.6K.
  • Amgen made up 1.62% of Peloton Wealth Strategists's portfolio in Q1 2026, its #21 holding.
  • Peloton Wealth Strategists first reported a position in Amgen in Q2 2020 and has held it in 24 quarters since.
  • Peloton Wealth Strategists's Amgen position peaked at $5.98M in Q2 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Peloton Wealth Strategists's 13F filing for Q1 2026, filed 14 May 2026.